Articles publiés

Caron C, Dondaine T, Bastien A, Chérot N, Deheul S, Gautier S, Cottencin O, Moreau-Crépeaux S, Bordet R, Carton L.Psychiatry Res. 2024 Jan;331:115630. doi: 10.1016/j.psychres.2023.115630. Epub 2023 Nov 25.PMID: 38043409

Daveluy A, Bryan MC, Miremont-Salamé G, Lassalle R, Lacueille C, Grelaud A, Floccia M, Haramburu F, Lapeyre-Mestre M, Micallef J, Salvo F. Analgesic switching in chronic users of dextropropoxyphene in France. Fundam Clin Pharmacol. 2023 Oct 21. doi: 10.1111/fcp.12962. Epub ahead of print. PMID: 37864449.

Louise Carton, Axel Bastien, Nathalie Chérot, Clément Caron, Sylvie Deheul, Olivier Cottencin, Sophie Gautier, Sophie Moreau-Crépeaux, ThibautDondaine & Régis Bordet (2023) An overview of the use of psychoactive substances among students at the University of Lille during the COVID-19 health crisis: Results of the PETRA study, Dialogues in Clinical Neuroscience, 25:1, 101-111, DOI: 10.1080/19585969.2023.2268063

Djezzar S, Gaulier JM, Gorgiard C, Chèse M, Alvarez JC, Martin C, Dumestre-Toulet V, Lavit M, Mathieu O, Eysseric H, Berland E, Roussel C, Gaillard Y, Hurtel-Lemaire AS, Deveaux M, Pion C. Assessment of 19 years of a prospective national survey on drug-facilitated crimes in France. Leg Med (Tokyo). 2023 Jul 13;65:102297. doi: 10.1016/j.legalmed.2023.102297. Epub ahead of

Fortanier E, Berling E, Zanin A, Guillou AL, Micaleff J, Nicolas G, Lozeron P, Attarian S. How to distinguish Guillain-Barré syndrome from nitrous oxide-induced neuropathy: A 2-year, multicentric, retrospective study. Eur J Neurol. 2023 Jul 26. doi: 10.1111/ene.15998. Epub ahead of print. PMID: 37494104.

Willeman T, Grundig N, Pochon C, Michels D, Charpentier N, Eysseric-Guérin H, Fouilhé Sam-Lai N, Stanke-Labesque F, Revol B. NPAideS: a drug-checking study among 3-methylmethcathinone (3-MMC) users. Harm Reduct J. 2023 Jul 28;20(1):96. doi: 10.1186/s12954-023-00836-4. PMID: 37507699; PMCID: PMC10375651.

Perino J, Ramaroson H, Ong N, Bezin J, Gilleron V, Daveluy A, Tournier M. General hospital admissions in young and middle-aged people who use psychoactive substances: Impact of Covid-19 lockdowns. Int J Drug Policy. 2023 Aug;118:104082. doi: 10.1016/j.drugpo.2023.104082. Epub 2023 Jun 8. PMID: 37336071; PMCID: PMC10247883.

Revol B, Willeman T, Manceau M, Dumestre-Toulet V, Gaulier JM, Fouilhé Sam-Laï N, Eysseric-Guérin H; Compagnie Nationale des Biologistes et Analystes Experts (CNBAE) and the French Addictovigilance Network (FAN). Trends in Fatal Poisoning Among Drug Users in France From 2011 to 2021: An Analysis of the DRAMES Register. JAMA Netw Open. 2023 Aug 1;6(8):e2331398. doi: 10.1001/jamanetworkopen.2023.31398.

Perino J, Demourgues M, Ramaroson H, Bezin J, Micallef J, Miremont-Salamé G, Frauger E, Gilleron V, Ong N, Daveluy A. Increase in hospitalisation-associated methadone intoxication in France following first COVID-19 lockdown. Public Health. 2023 Aug 10;223:1-6. doi: 10.1016/j.puhe.2023.07.004. Epub ahead of print. PMID: 37572562.